See the DrugPatentWatch profile for cosentyx

Based on the information available, there is currently no evidence to suggest that taking Cosentyx (secukinumab) after receiving a COVID-19 vaccine is unsafe [1]. However, it is always recommended to consult with a healthcare provider before starting or continuing any medication after receiving a vaccine.

Cosentyx is a medication used to treat several conditions, including plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis [2]. It is a type of drug called a monoclonal antibody, which works by targeting a specific protein in the body to reduce inflammation [3].

COVID-19 vaccines, such as those developed by Pfizer-BioNTech and Moderna, have been shown to be safe and effective in preventing COVID-19 infection [4][5]. Like any vaccine, they can cause side effects, but these are typically mild and go away on their own within a few days [6].

It is important to note that while there is no evidence to suggest that taking Cosentyx after receiving a COVID-19 vaccine is unsafe, it is always best to consult with a healthcare provider to ensure that it is safe for an individual's specific situation [1].

Sources:

* [1] <https://www.drugpatentwatch.com/covid-19-and-cosentyx-secukinumab-what-you-need-to-know/>
* [2] <https://www.cosentyx.com/about-cosentyx/what-is-cosentyx>
* [3] <https://www.mayoclinic.org/diseases-conditions/psoriatic-arthritis/diagnosis-treatment/drc-20354076>
* [4] <https://www.cdc.gov/vaccines/covid-19/info-by-product/pfizer/index.html>
* [5] <https://www.cdc.gov/vaccines/covid-19/info-by-product/moderna/index.html>
* [6] <https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/pregnancy.html>